Novartis AG - Sandoz Capital Markets Day (UK) Transcript
Great. Can everybody hear? So good morning, everybody. Thank you so much for making your way here to the London Stock Exchange for our Capital Markets Day for Sandoz, and thank you to the people who are listening on the web, too. I apologize for some of the conditions here. It's rather warm in here so do feel free to take off your jackets and things if you need to, and we're trying to fix the air conditioning here.
So a great pleasure to have the whole Sandoz team here with us, and we'll be getting on with the program very shortly. Just a word or two. This slide, which is Slide 4, for the people on the web, goes through the agenda itself. And we've actually divided the day up into 4 sessions. The first session after I finish will be with Gilbert Ghostine, the Chairman-Designate; and Richard, the Chief Executive Officer for Sandoz. We're going to actually be talking then about business strategy, the investment proposal, et cetera. Following that, in the second session, we'll be talking about the commercial aspects of Sandoz, and we'll have the 3 business
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |